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INTRODUCTION 
Bovine respiratory disease (BRD) complex is of substantial 
economic importance to cattlemen in the United States. An estimated 
40-80% of all cattle diseases involve the respiratory system (22). 
Although cattle may recover, cost of treatment and loss in production 
make respiratory disease an important factor to consider in the cattle 
industry. 
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In 1974, 407,000 yearling feedlot cattle in Colorado were surveyed 
for the causes of illness and death. The morbidity was 5.1% with a 
case mortality of 18.9%. Approximately 75% of the clinical diagnoses 
and 64% of the necropsy findings indicated respiratory tract diseases 
(14). 
Viruses are obligate intracellular parasites that must enter 
susceptible cells of the host in order to replicate and cause disease 
(1_). Specific defense mechanisms such as cell-mediated immunity (CMI) 
and/or humoral immunity (HI) become active in preventing viral 
multiplicat ion (29). 
Three bovine herpesviruses, Bovid herpesvirus 1 (BHV-1), Bovid 
herpesvirus 3 (BHV-3), and Bovid herpesvirus 5 (BHV-5), have been 
associated with respiratory disease. The bovine immune response to 
BHV-1 has been studied using the serum neutralization (SN) test -to 
evaluate levels of humoral antibody and the lymphocyte immunostimulation 
(LI) test to monitor CMI (8, 11, 30). The ability of BHV-1 to become 
latent in host cells and to be reactivated in experimentally infected 
calves following treatment with corticosteroids has also been 
2 
reported . (8, 9, 33). 
While the HI response of cattle to BHV-3 has been monitored using 
the SN test (25), no data is available on the CMI response or the 
reactivation of this herpesvirus in naturally or experimentally infected 
cattle following corticosteroid treatment. 
A search of the literature did not reveal studies monitoring the 
HI or CMI responses of naturally or experimentally infected cattle to 
BHV-5 or the recrudescence of this virus following corticosteroid treat-
ment. Since such studies aid in understanding the specific immune 
responses of calves to herpesvirus (HV) infections, experiments were 
carried out using the indirect immunofluorescent (IIF) test to monitor 
the HI response, and the LI assay to monitor the CMI response of calves 
to BHV-5. The effect of a corticosteroid on the immune response to and 
recrudescence of this virus was also studied. 
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LITERATURE REVI EW 
Character i s tics and classification of herpesviruses .· The 
International Committee on the Taxonomy of Viruses has defined the 
morphologic, physical, and chemical properties of the genus 
Herpetoviridae. The characteristics include: an enveloped icosahedral 
capsid consisting of 162 capsomers; a double-stranded linear deoxyribo-
nucleic acid genome; a diameter of 90-110 nm non-enveloped and 110- 150 
nm enveloped; a particle weight of 54-92 x 106 daltons; a G-C ratio 
54-74%; sensitive to acid, heat, and lipi d solvents; inhibition by halo-
genated deoxyuridines, and replication i n the host cell nucleus (1, 10). 
This committee also separated and r enamed the herpesviruses into 
families based on host preference. The fami lies were sub-divided into 
groups on the basis of antigenic differences (35). The renamed bovine 
herpesviruses appear in Table I. 
Bovine herpesviruses implicated with respiratory disease. Bovine 
respiratory disease co·mplex had been defined as "an acute or subacute 
infiammatory reaction within the nose, paranasal sinuses, larynx, 
trachea, br onchi, and lungs" (13). The cause of BRD is complex and one 
or more species of viruses, bacteria, or mycoplasmae, acting alone or in 
synergism, have been implicated (22). The bovine herpesviruses, BHV-1, 
EHV-3, and BHV-5, have been mentioned as possible causes of respiratory 
disease. Infectious bovine rhinotracheitis virus (BHV-1) is known to 
cause respiratory infection without assistance from other factors 
(22, 35) . Approximately 3% of BHV-1 infect ed cattle die, usually from 
bronchopneumonia. The symptoms associat ed wi th BHV-1 may include fever, 
nasal and ocular discharge, and abortion . (6). 
Table I. Bovine herpesviruses 
New Name 
Bovid herpesvirus 1 (BlN-1) 
Bovid herpesvirus 2 (BHV-2) 
Bovid herpesvirus 3 (BHV-3) 
Bovid herpesvirus 4 (BHV-4) 
Bovid herpesvirus 5 (BHV-5) 
Bovid herpesvirus 6 (BHV-6) 
Pr evious Name 
Infectious bovine rhinotracheitis 
Bovine mammillitis virus 
Malignant catarrhal fever 
Progres s ive pneumonia of sheep 
Movar 33/63 
DN-599 
FTC-2 
DDV-71 
Vll 
CK-54 
BPX/11 
BH~l247 
Clark M/20 
Bovid herpesvirus-3 causes malignant catarrhal fever, which is an 
acute, usually fatal disease. A catarrhal inflammation of t he upper 
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respiratory and alimentary epithelium, keratoconjunctivitis, encephali-
tis, cutaneous exanthema, necrotic arteritis, and l ymph node 
enlarg~ment are symptoms observed with this disease . While lesions are 
commonly observed in the trachea and bronchi, the l ungs are usually not 
involved (6). 
Most of the known BHV-5 viruses have been iso l ated within the last 
decade in various geographic areas of the United St ates. Many isolates 
have been obtained from calves with symptoms of r espiratory disease 
(17 J 36). In 1971, Mohanty et al. {17) in Mar yl and i solated a bovine 
I --
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herpesvirus (DN-599) from an 18-month-old steer with respiratory 
disease . This isolate produced typical respiratory disea~e when 7-week-
old calves developed temperature elevations, nasal discharges, coughs, 
hyperpnea, and dyspnea. Lesions were produced in the lungs. According 
to Smith (35), Bartha isolated BIN-S (Movar 33/63) from cattle with 
respiratory disease in Hungary. He could not demonstrate this virus to 
be pathogenic when .inoculated into calves via the respiratory route. 
Smith and co-workers (36) isolated BHV-5 (FTC-2) from the trachea and 
retropharyngeal lymph nodes of Colorado feeder steers. Intratracheal 
inoculation of two 2- to 4-month-old calves produced mild clinical 
. respiratory disease with microscopic lesions of necrotizing lymphocytic 
pharyngitis and tracheitis. · These isolates, DN-599, Movar 33/63, and 
FTC-2, were not neutralized by antise.ra against other known herpesviruses. 
Other serotypes of BHV-5 have been isolated from cattle with 
symptoms other than respiratory signs. Parks and Kendrick (20) isolated 
DDV-71 from the uterine exudate of a cow. Vander Maaten and Boothe 
(38) isolated -VII from leukocytes of two cows with lymphosarcoma. Reed 
and co-workers (24) isolated BHv-5 from lactating dairy cows with 
lesions of mammary pustular dermatitis. Several isolates of BHV-5· have 
been recovered from clinically normal cattle (22). 
Pathogenicity of BHV-5. Bovid herpesvirus Group 5 appears to 
infect cattle of all ages and has been isolated from several different 
organs in cattle. The pathogenicity of BHV-5 in calves is not clear 
because results of experimental infections range from no clinical 
disease (22) to severe respiratory disease involving temperature 
elevation, nasal discharge, coughing, hyperpnea, and dyspnea (17). 
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Cytopathic effect of BHV-5 in vitro~ ~fultinucleated masses of 
fused cells with intranuclear inclusion bodies are among the cytopathic 
effects (CPE) produced when susceptible cell lines are infected with 
BHV-5. Many cell lines are susceptible to BHV-5 including primary 
bovine embryonic kidney cells, Madin Darby bovine kidney (~IDBK) cells, 
bovine embryo tracheal cells, . bovine embryo lung (BEL) cells, and 
bovine fetus bone marrow cells (20, 21, 36). 
Cell-mediated immunity. . The lymphocyte immunostimulation test is 
one of several in vitro techniques used as correlates of CMI (2). The 
LI test has been used to monitor the CMI response of experimentally 
infected animals to various herpesvirus (HV) infections. Lymphocyte 
blastogenesis was detectable after 5 days, peaked at 7-10 days, and 
declined to low levels by day 19 with intranasally BHV-1 infected 
calves (30). Alhaji and co-workers (2) detected stimulation of lympho-
cytes within 3 days after infection of cattle with BHV-1, reaching a 
maximum response 12-14 days post infection (p.i.), and declining by 
day 15. Rosenberg and Notkins (27) detected a CMI response at 3 days in 
4 rabbits inoculated with herpes simplex virus (HSV), a herpesvirus of 
humans. A maximum response was reached 7 days p.i. and decreased by 
day 14. Pseudorabies virus (PRV), a herpesvirus of swine, was 
inocuiated intranasally into pigs by Rottinghaus and co-workers (28). 
A CMI response was detected on day 6; peaking on day 13 ·or 14, and 
remaining elevated throughout the study. 
Humoral immunity. Studies monitoring antibody production in 
experimentally infected animals involving BHV-1 (8), PRV (28), and HSV 
(27) reported detection of antibody 7-14 days p.i., leveling off 
approximately 19 days after infection. 
Latency. Many herpesviruses (BHV-1, HSV, PRV) have been shown to 
have the ability to become latent in the host cell and be reactivated 
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at a later date (1, 33, 37). Viral latency is a state in which the 
genome of the virus is present in the host cell with no release of 
infectious virus (23). Upon reactivation, infectious virus is again 
released in the host, but the exact mechanism involved in reactivation 
of latent virus is not known. Latent viruses may be reactivated by 
treating the infected animal with corticosteroids (9). The effect of 
corticosteroids on the immune system is not fully understood, but an 
initial suppression of CMI usually follows steroid treatment (8, 18}. 
During this immunosuppression, virus may be reactivated and allowed to 
multiply possibly resulting in clinical signs. For example, recurrent 
"cold sores" may appear upon reactivation of HSV in man (23). The nerve 
cells appear to harbor herpesviruses in the latent state (4, 19, 32). 
Herpes simplex virus aJ1d BHV-1 have been recove-red from trigeminal 
ganglia of animals experimentally infected with these viruses using 
organ cultures (8, 19). 
There have been few reports on CMI response after treatment of 
calves with corticosteroids. In 3 of 4 calves experimentally infected 
with BHV-1 and treated 3 months later with dexamethasone (OM) or adreno-
corticotropin (ACTH), Davies and Carmichael .reported a CMI response 
within a day after the 5th day of treatment, peaking within 9 days (8). 
The CMI response returned to pre-treatment values by day 13 in the 
ACTH-treated calves whereas the response of OM-treated calves remained 
elevated. Inconsistent results have occurred in herpesvirus studies 
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involving antibody detection after corticosteroid treatment. Some report 
no detect ion of antibodies while others detect an immediate response (9, 
13, 23, 16). The role of CMI and HI in BHV-5 infected calves prior to 
or after corticosteroid treatment has not been reported. 
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MATERIALS AND METHODS 
In Vitro Procedures 
Media. Cell culture growth media consisted of Eagle's Minimum 
Essential Medium (MEM) (Grand Island Biologic Co., Grand Island, NY) 
prepared with Earle's balanced salts, s~pplemented with non-essential 
amino acids, 10% fetal bovine . serum (FBS) (10% MEM), 0.5% lactalbumin 
hydrolysate, 0.01% pyruvic acid, 0.03% L-glutamine, and the following 
antibiotics: 100 units/ml penicillin; 100 ug/ml streptomycin; and 100 
ug/ml kanamycin. Cell culture maintenance medium consisted of MEM 
prepared as above but supplemented with 2% FBS (2% MEM). Hank's 
balanced salt solution (HBSS) (Grand Island Biologics Co., Grand Island, 
NY) was supplemented with 0 . ~5% NaHC03 and the antibiotics . as described 
for 10% MEM. Agar-overlay medium was prepared as a 2X concentration of 
MEM (2X MEM) with 0.6% Hepes, 0.06% 1-glutamine, 0.02% Na pyruvate, 300 
~its/ml penicill in; 200 ug!ml streptomycin; and 200 ug/ml kanamycin. 
Ion agar (Colab Laboratory, Science Park, Glenwood, IL) (0.6%) 
containing 40 ug/ml of DEAE dextran was dissolved in distilled water 
and autoclaved. The agar-overlay medium _was prepared fresh for each 
test by mixing equal volumes of melted agar and 2X MEM and adjusting 
the temperature to 48°C. This medium was used for BHV-5 plaquing. -
fl.gar-overlay medium for BHV-1 plaquing was the same as above, only the 
Hepes was omitted in the 2X MEM; and 1.4% ion agar was used instead of 
0.6%. Roswell Park Memorial Institute (RPM!) Medium 1640 (Grand Island 
Biologic Co., Grand Island, NY) used in· the LI test was supplemented 
with 15% FBS, 100 units/ml penicillin, and 100 ug/ml streptomycin. 
• 
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Cell cultures. Bovine embryonic lung (BEL) , bovine embryo (BE), 
and normal corneoscleral tissue (NCS) were cul tured and harvested using 
methods described by Whitaker (39). A continuous cell line, ~IDBK cells, 
was received from Dr. A. Matchett, Veterinary Biologi cs, National 
Animal Disease Laboratory, Ames, IA. Stock cul tures of each cell type 
were trypsinized, suspended in 10% MEM containing 7.5% dimethyl sulf-
oxide (Fisher Chemical Co., Chemical Manufacturing Division, Fair Lawn, 
NJ) and kept frozen at -70°C until used. 
Plaque assay. Monolayers of BEL cells were trypsinized and 
suspended in 10% MEM. Dilutions of 10-1 to 10- 8 of BHV-5 were made 
with HBSS. Four ml of the cell suspension, containing approximately 
106 cells/ml, and 2 ml of each of the virus dilutions were seeded in 
60 mm petri dishes (Falcon Co., Oxnard, CA). The cultures were 
incubated 48 h at 37°C in a 5% C02 humidified atmosphere. After 
decanting the medium, the cells were overlayed wi t h 5 ml agar-overlay 
medium. The medium was allowed to solidify, the plates were inverted, 
and incubated 36 to 48 h -at 37°C. To examine the plates for plaque 
formation, the overlay was removed with a spatula, and the cells were 
flooded 3 min with a stain prepared by mixing equal amounts of crystal 
violet ·and 10% phosphate buffered formalin pH 7 . The monolayers were 
then washed with tap water to remove the excess s tain, and plaques were 
counted. 
Bovine embryo lung cells were seeded in 60 mrn petri dishes with 10% 
MEM and incubated 24 h in a 5% C02 humidified incubator at 37°C. Dilu-
tions of 10-l to 10-8 of BHV-1 were made with HBSS. The medium was 
decanted from the petri plates, and each of the virus dilutions (0.5 rnl) 
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was adsorbed 1 h onto each of the monolayers. After decanting the virus 
suspension, the cells were overlayed with 5 ml agar-overlay medium and 
incubated for 36 to 48 h at 37°C. The plates were observed for plaque 
formation. 
Plaque purification. The method used for selecting and harvesting 
plaques was that of Rovozzo and Burke (32). Plaque formation -could be 
detected in unstained monolayers with the aid of an inverted light 
microscope. 
Fluorescent antibody test. The method used to detect BHV-1 in cell 
cultures was the fluorescent antibody (FA) procedure of Rovozzo and 
Burke (32). 
lmrnuno-electron microscopy (IEM). Virus-infected BEL cells were 
frozen, thawed, and scraped from the ~urface of a 75 cm2 flask (Corning 
Glass Works, Corning, NY) with a rubber policeman . The celi suspension 
was centrifuged 1 hat 60,0.00 x g to concentrate the virus. · The 
supernatant was decanted, and the pellet was -resuspended in 6 drops of 
distilled water. The suspension was divided equally into 2 tubes. 
Three drops of known specific antiserum was added to 1 tube, and 3 drops 
of distilled water was added to the other. The latter was used as -
untreated virus control. The tubes were incubated 12 h at 4°C. The 
suspensions were centrifuged 1 h at 60,000 x g and the supernatant 
decanted. Each pellet was suspended in 3 d:r:ops of distilled water and 
negatively stained with 4.0% phosphotungstic acid using the procedure 
described by Ritchie and Fernelius (26). The electron microscope 
(Hitachi HU-12) was used for examination of the stained preparations. 
Virus isolation from tissue samples. Tissue portions were 
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collected and ground with a mortar and pestle and fine sterile silica 
sand. A 10% suspension of each tissue was made with HBSS. The suspen-
sion was centrifuged 20 min at 3,000 x g. A 75 cm2 flask of BEL cells 
was suspended in 60 ml 10% MEM. One ml of this suspension was put into 
~ach of 60 disposable culture tubes (16 mm x 125 rnm) (Becton, Dickenson 
and Co., Rutherford , IL) and i~cubated at 37°C in a 5% COz humidified 
incubator until cell monolayers were observed. Two-tenths ml of the 
supernatant of each tissue was added to each of two tubes and allowed 
to adsorb 1 h at 37°C in a 5% C02 humidified incubator. The remainder 
of the inoculum was then decanted and replaced with 2% MEM. The cel J. 
cultures were incubated at 37°C and examined daily for CPE. When no 
apparent CPE was detected after 7 days, the monolayers were frozen, 
thawed, and passed onto fresh· cell rnonolayers. lf no CPE was evident 
after 3 passages, the inoculum was considered free of virus. 
A BHV-5 isolate, designated as #77-4019, was isolated from the 
lung, spleen, and liver of a 5-week-old Holstein calf that had been 
submitted to the South Dakota Animal Disease Research and Diagnostic . 
Laboratory, Brookings, SD. The ¥irus was passed 5 times on cell 
culture, stored at -70°C and was used as inoculum for this study. 
Virus isolation from nasal swabs. The nostrils of each calf were 
swabbed with a sterile piece of cotton on an applicator stick, and the 
swab was suspended 1 h in 5 ml HBSS. The fluid was filtered through a 
220 nm filter (Millipore Corp., Bedford, ~tA). Two-tenths rnl of the 
filtrate was inoculated into each of 2 culture tubes monolayered with 
BEL and BE cells and allowed to adsorb in a COz humidified incubator at 
37°C. The inoculum was decanted and replaced with 1 ml 2% MEM. The 
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cultures were incubated at 37°C and examined daily for CPE. The 
inoculum was considered free of virus if after 3 passages no CPE was 
apparent. 
Virus isolation from organ cultures. Tissue sections (2 rnm3) were 
mounted on s terile 1 x 2 x 3 mm sponges (Gelfoam, The Upjohn Co., 
Kalamazoo, MI) that had been soaked in 10% MEM. The sponges were then 
placed in 60 rnm petri dishes containing 5 ml 10% MEM. The petri dishes 
were decanted and replaced with fresh medium every 24 h. Two-tenths ml 
of the decanted medium was inoculated into each of 2 culture tubes 
monolayered with BEL cells and allowed to adsorb for 1 h in a 5% COz 
humidified incubator. The inoculum was decanted and replaced with 1 ml 
2% MEM. The cultures were incubated at 37°C and examined for CPE daily 
for 7 days . If no CPE could be detected by the end of t hat period, the 
cultures were frozen, thawed, and inoculated onto fresh monolayers of 
cells. Each cur'ture was passed 3 times before it was considered free of 
virus. The viruses isolated were identified by· FA or IEM procedures. 
Serum neutralization test. The serum neutralization (SN) test was 
used .to monitor the calves' humoral immune responses to BHV-1. This 
t~st was performed in a microtiter system according t o the methods · 
described by Black (5). Briefly, blood was collected from each animal, 
and the serum was inactivated 30 min in a 56°C water bath. Two-fold 
dilutions (1:2 to 1:512) of the serum were made with 2% MEM and mixed 
with diluted virus (600 PFU/0.05 ml) in wells of microtiter plates. The 
plates were incubated 1 hat 37°C. A·suspension of MD BK cells in 10% 
MEM was added to each well, and the plates were incubated 72 h at 37°C, 
examined, and the results recorded. The SN titer wa s expressed as the 
355128 
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reciprocal of the highest dilution of serum in which no CPE occurred. 
Indirect immunofluorescent test. The indirect immunofluorescent 
(!IF) test, similar to that described by Assaf et ~· (3), was used to 
monitor the calves' humoral immune responses to BHV-5. Four-chambered 
tissue culture slides (Lab-Tek Products Division, Miles Laboratories, 
Inc., Naperville, IL) were see~ed with BEL cells suspended in 10% MEM 
(0.5 ml/chamber) . The cultures were incubated 24 hat 37°C in a 5% C02 
humidified atmosphere. Virus #77-4019 (0.025 ml) was inoculated into 
each chamber of the slide cultures, incubated at 37°C, and the slides 
were removed when CPE was observed in SO% of the cells. The slides w,·re 
fixed 1 h in cold acetone after which they were removed and stored at 
-70°C. Two-fold dilutions (1 ·:2 to 1 :512) of the test serums were 
prepared in phosphate-buffered saline .CPBS). Each chamber was 
inoculated with a serum dilution, which was allowed to adsorb 30 min at 
37°C. The slides were rinsed 15 min in 2 changes of PBS, and the excess 
fluid was removed by blotting with a paper towel. They were flooded 
with fluorescein conjugated IgG fraction rabbit anti-bovine IgG (Cappel 
Laboratories, Cochranville, PA) ~1:30 dilution) and incubated 30 min 
at 37°C. The slides were rinsed again with PBS, cover slipped using FA 
mounting fluid (pH 9) (Difco Laboratories, Detroit, MI), and examined 
for fluorescence . Similar cell culture slides treated with known 
positive BHV-5 serum and others treated with_ PBS were used as positive 
and negative controls, respectively. 
Viral antigens for lymphocyte irnrnunostimulation test. Four 75 cm2 
flasks monolayered with BEL cells were each infected with 1 ml of virus 
177-4019 and observed daily until CPE was observed in 80% of the cells. 
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The cell cultures were frozen and thawed · 3 times; then sonicated 5 sec 
at 20,000 Hz (Sonifier Cell Disrupter, Model Wl85, Heat Systems-
Ultrasonics, Inc., Plainview, NY). The culture fluids were pooled and 
centrifuged 10 min at 2,000 x g to remove cellular debris. The viral 
suspension was partially purified by centrifuging it at 40,000 x g for 
1 h. The supernatant was discarded, and the pellet resuspended in HBSS 
to 0.1 of the original volume. The viral suspension was inactivated 20 
min under ultraviolet light at a distance of 12 i nches (General Electric 
germicidal lamp #Gl578). Ten-fold dilutions (lo-1 to lQ-4) of this 
concentrate were made with RPMI-1640. 
The same procedure was also employed for the preparation of the 
BHV-1 antigen. 
Lymphocyte imrnunostimulation test. Lymphocyte immunostimulation 
(LI) was employed to monitor the calves' CMI responses to a specific 
antigen. Blood from each calf was collected in tubes containing 
preservative-free heparin (5 IU per ml of blood). The Ficoll-Hypaque 
method of separat ing lymphocytes from other blood components was used as 
· described by Rouse and Babiuk (29). The lymphocytes were washed twice in 
HB~S and centrifuged 10 min at 170 x g. The supernatant was decanted, 
and the -cells were resuspended in 8 ml of RPMI-1640. An automated cell 
counter (Coulter Electronics, Inc., (Model F), Hialeah, FL) was used to 
enumerate lymphocytes. The cell concentration was adjusted to 2.5 x 106 
cells/ml with RPMI-1640. 
RPMI-1640 and phytohemagglutinin-M (1 mg/ml) (Difco Laboratory, 
Detroit, IL) were used as negative and positive controls, respectively. 
Five-hundredths ml of each control was added to each of 4 wells on a 
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microtitration plate (Falcon 3040, Oxnard, CA). Antigens to be tested 
were diluted as previously described, and 0.05 ml of each antigen dilu-
tion was added to each of 4 wells of another plate. Two-tenths ml of 
the lymphocyte suspension was added to all wells on both plates. The 
plates were covered and incubated at 37°C in a 5% C02 humidified atmo-
sphere. The plate containing P.hytohemagglutinin-M was incubated 72 h; 
and those plates with the viral antigens were incubated 120 h. 
Immediately after incubation, 0.05 ml of 3HdT (spec. act. 66.9 Ci/ 
mmoles, 0.5 u Ci/well) (ICN Pharmaceuticals, Inc., Irvine, CA) in RPMI-
1640 medium was added to each culture. The cultures were reincubated 18 
h under the same conditions. The cultures were then refrigerated at 4°C. 
A lymphocyte harvester (Microbiological Associates (MASH I I) ·, 
Bethesda, MD) was used to collect the nucleic acid of the l)rmphocytes. 
The cells in each well were collected on glass fiber filters (Whatman, 
Inc., (Grade 934 AH), Clift~n, NH), washed 10 times with distilled 
water, and dried 2 h at 80°C .· Filters were placed in separate scintil-
lation vials containing 3 _ml of scintillation fluor (0.08 g bis-MSB 
(p-bis (0-methylstyryl) -benzene) .and 3.92 g PPO (2 .5 diphenyl-oxazole)) 
per liter of toluene. A liquid scintillation spectrometer (Model 3375, 
Pachard .Instrument Co., Inc., Downers Grove, IL) counted disintegrations/ 
min of the 3HdT in each sample. The degree of blastogenic transformation 
was determined by a stimulation index (SI). Stimulation index equals 
the mean count per minute of the 4 wells of a specific antigen or 
mitogen, divided by the mean count per minute of the RPMI-1640 control. 
Necropsy. One animal inoculated with BHV-5 was killed weekly 
starting approximately 2 months after DM treatment. ·A control calf (#81) 
was also necropsied. 
Histopathology. 
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Lung tissues were examined for gross lesions. 
Lung samples were fixed in formalin and embedded 
in paraffin. Six-micron sections were cut and stained with hematoxylin 
and eosin and submitted for histologic examination. 
Virus isolation. Virus isolation was attempted on the lung, 
spleen, liver, lymph nodes, ad~enal gland, brain, tonsil, spinal cord, 
and trigeminal ganglion of each necropsied animal using tissues and 
organ culture techniques previously described. 
In Vivo Procedures 
Source and housing of animals. Eight 4-month-old crossbred and 
Holstein calves were purchased, and each was identified by eartag_. 
Animals were tested for BHV-1 by the SN test and f~r BHV-5 by the IIF 
test. The animals were then divided into 3 groups and isolated in 
different buildings. One group was treated ·with BHV-1; one group with 
BHV-5; and the other group of untreated animals served ·as the controls. 
Inocula. Bovine embryonic lung cells were seeded into 75 cm2 
tissue culture flasks with 30 ml 10% MEM. The flasks were incubated 
24 h at 37°C in a 5% C02 humidified incubator. The growth medium was 
replaced with 2% MEM, and each flask was inoculated with 1 ml virus 
177-4019 (BHV-5) or l ·ml BHV-1 virus (National Animal Disease 
Laboratory, Ames, IA). The cultures were incubated at 37°C in a . 5% C02 
humidified atmosphere until approximately 80% of the cells had CPE. The 
cultures were frozen at -70°C and thawed 3 times. Following centrifu-
gation for 10 min at 2,000 x g, the supernatant was collected and stored 
at -70°C until used. The cell culture infective titer of BHV-5 and 
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BHV-1 inocul a were 3.5 x 105 PFU/ml and 3 x 107 PFU/ml, respectively. 
The control calves were inoculated with a placebo consisting of 2% MEM. 
Inoculation procedures. The calves were inoculated with viruses 
by 3 different routes: intranasally (IN), intratracheally (IT), and 
intradermal ly (ID) . An atomizer (Rals Laboratories, Northfield, OH) 
was used for IN inoculations. Intratracheal inoculations were made by 
needle puncture between tracheal rings. Intradermal inoculations were 
done with a 23 gauge needle into the caudal fold of each calf. Each 
calf was also treated 5 consecutive days with 5 ml (2 mg/ml) dexame-
thasone (DM) (Azium Oral Solution, Schering Corp., Bloomfield, NJ) 
intramuscularly (IM). 
Inoculation of cattle with BHV-1 induces both a CMI and HI response 
(11). Therefore, to demonstrate that proper methods were used for 
testing the CMI response to BHV-5, two calves (#77, #80) in Group I were 
inoculated ID with 1 ml (3 x 107 PFU/ml) of BHV-1 inoculum on day 0 
(initial inoculation), 1 ml ID on day 24, and 3 ml IN on day 39. On days 
108-112, DM treatment was administered. 
On days 0 and 24, calves (#78, #79, #82, #83) of Group II were 
inoculated with 5 ml IN and 5 ml IT of BHV-5 (3.5 x 105 PFU/ml). On 
day 48, 1 ml of the BHV-5 inoculum was injected ID into the caudal fold. 
Beginning on day 75, 5 ml DM was injected IM daily for 5 days. Calf #78 
was treated with DM a second time 5 days prior to necropsy. 
The contro l calves (#76, #81) in Group III were inoculated the same 
as the experimental calves in Group II using the placebo. 
Samplings and clinical observations. From Group II (BHV-5 infected 
calves) and Group III (control calves) rectal temperatures were taken, 
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and the animals were observed for clinical signs of respiratory infec-
tion daily for 11 consecutive days beginning on day 0. Nasal swabs and 
2 blood samples were collected weekly starting 35 days prior to day 0 
and bi-weekly or weekly for 123 days after day 0. One blood sample was 
allowed to clot, and the serum was tested by IIF for specific humoral 
antibody to BHV-5. The second blood sample was heparinized, and the 
lymphocytes harvested and evaluated by the LI test for CMI response. 
Virus isolation from the nasal swabs was attempted as previously 
described. 
From Group I (BHV-1 infected calves) blood samples were collect~d 9 
days prior to day 0 and bi-weekly or weekly for approximately 152 days 
after day 0. The SN test was used for BHV-1 antibody detection, and the 
LI test was used to monitor the CMI response to BHV-1 antigen. 
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RESULTS 
Virus isolate identification. Cytopathic effect on BCS and BEL 
cells was evident 5 days after inoculation of #77-4019 inoculum. In the 
cultures there were multinucleated masses of cells with cytoplasmic 
streaming and intranuclear inclusion bodies typical of herpesvirus 
infection (Figs. 1, 2, 3). When scrapings of the cell monolayers 
showing CPE were tested for BHV-1 using the FA ~echnique, no fluores-
cence was observed. The IEM test revealed a positive reaction with 
BHV-5 antiserum . 
Clinical signs. Two of the 4 calves inoculated with BHV-5 
developed mild respiratory signs including coughing and serous discharge 
from the eyes and nose on day ~· No fever was detected. The non-
inoculated control calves remained essentially normal with no apparent 
clinical signs or fever (Tables II, III). 
Humoral immune response. In Group I (BHV-1 infected calves), a 
low-level antibody response (1:2 titer) to BHV-t antigen was detected 
approximately 14 days aft·er initial inoculation (day 0) . The antibody 
level continued to increase until day 49 when a slight decrease and 
leveling off was observed. No appreciable rise in antibody production 
was detected following· DM treatment (Figs. 6, 7, and Table IV). · 
In Group II (BHV-5 infected calves), antibody to BHV-5 antigen was 
first detected 17-21 days post inoculation in all 4 calves (Figs. 4, 5). 
This response increased gradually; leveling off approximately day 35 
and gradually lowering by day 76. There was not a noticeable anamnestic 
antibody response upon subsequent infection. Within a week after DM 
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treatment, an increase in antibody production (gradual in -#78, #79, and 
#83; sharp in #82) was detected in all 4 calves (Figs. 8, 9, 10, 11, 
and Table V). 
Antibody to BHV-5 antigen was not detected in either control calf 
prior to or after DM treatment (Figs. 12, 13, and Table V). 
Cell-mediated immune response. In Group I (BHV-1 infected calves), 
lymphocyte stimulation was no greater than pre-treatment values in 
either of the two calves following their initial inoculation with BHV-1. 
One calf (#80) developed a stimulation index (SI) of 2.4 5 days after 
the second inoculation and maintained an SI of this value or greater ior 
approximately 21 days. Within a week after DM treatment, calf #80 had 
a SI of 3. 3 ~nd maintained it ·at 2. 0 or greater continuously for approx-
imately 42 days. The other calf (#77) .developed no detectable SI. 
throughout the experiments (Figs. 6, 7, and Table VI). 
Three of 4 calves (#78, · #82, #83) in Group II (BHV-5 infected 
calves) developed a CMI response 4 days after initial inoculation and 
maintained an elevated SI for approximately 21 days before dropping to 
lower levels. After the second inoculation on day 24, a CMI response 
was detected in the same 3 animals lasting a span of approximately 2 
weeks be.fore falling to pre-treatment of SI values. Upon inoculation on 
day 48, 2 (#82, #83) of the 3 animals showed an immediate CMI response, 
which peaked day 62 and dropped to pre-treatment SI values by day 76. 
The response in ·#78 was minimal. The other calf of the group (#79) 
developed a SI greater than 2.0 but not greater than 2.7 on 3 occasions: 
days 17, 24, and 27. After DM treatment on days 76-80, no significant 
CMI response occurred in calves #79 and #83 of Group II. In calves #78 
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and #82 a CMI response was detected approximately 10 days after the last 
day of treatment (Figs. 8, 9, 10, 11, and Table VII). 
Both control calves had SI's below 2.0 when tested with BHV-5 
antigen except on 2 days. The exceptions were marginal rises in SI's 
~o 2.14 and 2.2 recorded on days 4 and 10 in control calf #76 (Figs. 12, 
13, and Table VII). 
Clinical observations and necropsy results. Calves #83 and #82, 
necropsied 2 months and 2 1/2 months after DM treatment, respectively, 
appeared clinically normal. No lung lesions were observed in #83. A 
few focal, depressed, dark red lobular areas were distributed in the 
anterior ventral lobes of the lung of calf #82. Calves #78 and #79 were 
sacrificed 3 months after DM treatment. Calf #78 was treated with DM 
again 5 consecutive days just· prior to .necropsy. This calf showed 
serous nasal discharge at necropsy; calf #79 appeared clinically normal. 
Lung lesions, similar to tho.se in calf #82, were present in both of 
these calves. Control calf #81 was necropsied approximately 2 months 
after DM treatment. No respiratory signs were noticed, and no lesions 
were observed in the lungs. 
Histopathology. Histologic examination revealed areas of atelec-
tasis with peribronchiolar lymphoid hyperplasis in formalized sections 
of lungs of calves #78, #79, and #82 in Group II (BHV-5 infected calves). 
No microscopic abnormalities were observed ~n the lungs of control calf 
#81. 
Virus isolation. From Group II (BHV-5 infected calves), in the 2nd 
cell culture passage, a virus was isolated from the thoracic lymph node 
of calf #78 after the second 0~1 treatment. The virus was identified by 
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IEM as BHV- 5 (Figs. 14, 15). Virus was not isolated from other tissues 
of this cal f nor from tissues of calves #79, #82, and #83 upon necropsy. 
Virus was not isolated from organ cultures of calves #78, #79, or #83. 
After 5 days of incubation, a virus was i solated from the medium used 
on the organ cul tures of the spinal cord and trigeminal ganglion of calf 
#82. The virus was identified by IEM as BHV-5. With 1 exception, no 
virus was isol at ed from nasal swabs coll ected from Group II (BHV-5 
infected calves) prior to or after DM t reatment. When cell monolayers 
were inoculated with nasal swab inoculum obtained from calf #78 15 days 
after DM treatment~ CPE occurred. The virus was identified by IEM a~ 
BHV-5. Virus could not be isolated from a nasal swab obtained a week 
later from the same animal. 
Virus was not isolated from tissu~ samples, organ cultures, or 
nasal swabs of control calf #81 through 3 cell culture passages. 
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Table I I. Rectal temperatures of groups II (BHV-5 infected calves) and 
III (controls) 10 consecutive days after initial inoculation 
Temperature OF 
Group II Group III 
Calf Numbers Calf Numbers 
Experimental Days 78 79 82 83 76 81 
0 103.0 103.0 102 .6 103.2 102.4 102.6 
1 103.4 103.5 102.4 103.6 103.2 103.0 
2 102.8 104.0 102. 3 102.8 102.0 102.3 
3 103.0 103.0 102.6 103.6 102.3 102.0 
4 103.6 103.6 .103 . 0 103.0 102.6 102.2 
5 103.2 103.6 102.6 103.4 102.8 103.2 
6 102.7 103.4 102.0 103.0 103.2 103.0 
7 102.2 103.0 102.4 102.6 103.4 102.8 
8 104.0- 102.6 102.3 102.2 103.0 103.2 
9 103.0 102~6 102. 0 103.1 103.0 102.3 
10 102.4 102.6 102.6 102.2 102.0 102.0 
25 
Table III. Clinical observations of groups II (BHV-5 infected calves) 
and III (controls) 10 consecutive days after initial inoculation 
Group Calf# Observations 
II 78 Serous nasal discharge on Day 5 
79 Diarrhea on Day 5 
82 Serous nasal and eye discharge and 
coughing on Day 5 
83 Normal 
III 76 Normal 
81 Normal 
Table IV. Humoral immune response of group I (BIN-I infected calves) 
to BHV-1 antigen 
Experimental 
days 
0@ 
7 
14 
21 
30@ 
35 
39@ 
42 
45 
49 
52 
56 
59 
63 
70 
77 
84 
97* 
118 
125 
139 
146 
152 
159 
(-) No antibody detected 
* Steroid t reatment 
@ Virus inoculation 
Serum neutralization titer 
(reciprocal of dilution) 
77 
2 
4 
8 
16 
64 
8 
8 
128 
128 · 
16 
32 
16 
32 
16 
16 
16 
8 
16 
16 
4 
32 
16 
Group I 
Calf numbers 
80 
2 
2 
16 
8 
16 
32 
16 
128 
32 
16 
32 
16 
16 
8 
16 
16 
8 
8 
8 
8 
16 
8 
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Table V. Humoral immune 
and group I II (controls) 
Experimental 
days 78 
0@ 
7 
14 
17 
21@ 2 
24 
28 8 
35 32 
42 32 
49@ 32 
62 8 
76* 8 
83 16 
90 32 
96 32 
103 64 
117 64 
123 32 
(-) No ant ibody detected 
* Steroid treatment 
@ Virus inoculation 
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response of group II (BHV-5 infected calves) 
to BHV-5 antigen 
Indirect Immunofluorescent titer 
(reciprocal of di l ut i on) 
Group II Group III 
Calf numbers Calf numbers 
79 82 83 76 81 
2 2 
2 4 8 
4 8 32 
16 8 32 
16 32 32 
32 32 32 
32 32 32 
16 64 32 
8 8 8 
16 128 16 
32 128 32 
32 128 64 
64 128 128 
128 64 64 
32 64 64 
Table VI.. Cell-mediated immune response of group I (BHV-1 infected 
calves) to BHV-1 antigen 
Experimental 
days 
-9 
0@ 
7 
14 
21 
30@ 
35 
39@ 
42 
45 
49 
52 
56 
59 
63 
70 
77 
84 
97* 
Ill 
118 
.125 
132 
139 
146 
153 
(-) SI less than 2.0 
* Steroid treatment 
nt Not tested 
@ Virus inoculation 
77 
nt 
nt 
Stimulation indexes 
Group I 
Calf numbers 
80 
2.4 
4.5 
5.4 
3.5 
3.4 
3.0 
2.7 
nt 
3.3 
2.5 
7.8 
4.1 
2.0 
6.9 . 
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Table VII. Cell-mediated immune response of groups II (BHV-5 infected 
calves) and III (controls) to BHV-5 antigen 
Stimulation indexes 
Group II Group III 
Cal.f numbers Calf numbers 
Experimental 
days 78 79 82 83 76 81 
-35 
-28 
-21 
-14 
-5 
0@ 
4 3.4 2.5 4.9 2.1 
7 2.4 -
10 3.0 2.2 2.2 
14 3.4 2.5 
17 3.4 2.0 2.0 2.5 
21@ 2.7 2.1 
24 2.3 6.9 
28 3.9 2.7 2.7 
35 2.8 2.3 2.3 
42 
49@ 2.0 2.1 2.8 
62 3.5 3.8 
76* 2.4 
83 
90 3.6 2.3 
96 nt 2.4 2.9 
103 
110 2.4 2.8 
117 2.4 
123 6.9 
(-) SI less than 2.0 
* Steroid treatment 
nt Not tested 
@ Virus inoculation 
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Figure 1. Control bovine embryonic lung monolayer. X 128. 
Figure 2. Bovine embryonic lung cells inoculated with #77-4019 inoculum · 
exhibiting cytoplasmic streaming (arrows) . and accumulation of swollen 
nuclei (n). X 160. 
Figure 3. Cytopathic effect of #77-4019 inoculum on bovine embryonic 
lung cells. Note intranuclear inclusion bodies (arrow). X 384. 
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Figure 4. Bovid herpesvirus 5 infected bovine embryonic lung cells 
displaying nuclear and perinuclear (pn) fluorescence at a 1:32 dilution 
of serum from calf #83. Note syncylial (s) formation. Indirect 
immunofluorescent stain. X 80. 
Figure 5. Bovid herpesvirus 5 infected bovine embryonic lurig cells 
displaying intense nuclear (n) fluorescence at a 1:8 dilution of serum 
from calf #78. Indirect immunofluorescent stain. X 80. 
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Figure 6. Relationship between cellular and humoral immune response to 
BHV-1 in BHV-1 infected calf #77. 
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Figure 7. Relationship between cellular and humoral immune response to 
BHV-1 in BHV-1 infected calf #80. 
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Figure 8. Relationship between cellular and humoral immune response to 
BHV-5 and virus isolation in BhV-5 infected calf #78. 
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Figure 9. Relationship between cellular and humoral immune response to 
BHV-5 and virus isolation in BHV-5 infected calf #79. 
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Figure .10. Relationship between cellular and humoral immune response to 
BHV-5 and virus isolation in BHV-5 infected calf #82. 
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Figure 11. Relationship between cellular and humoral immune response to 
BHV-5 and virus isolation in BHV-5 infected calf #83. 
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Figure 12. Relationship between cellular and humoral immune response to 
BHV-5 and virus isolation in control calf #76. 
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Figure 13. Relationship between cellular and humoral immune response to 
BHV-5 and virus isolation in control calf #81. 
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Figure 14. Photomicrograph of BHV-5 isolated from calf #78. Incomplete 
(ic) and complete (c) particles are evident with a network of antibody 
(ab) between them. Immuno-electron microscopy test with BHV-5 
antiserum. X 85,000. 
Figure 15. Photomicrograph of BHV-5 isolated from calf #78 displaying 
envelopes (en) surrounding herpesvirus particles. Immuno-electron 
microscopy test with BHV-5 antiserum. X 65,000. 
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DISCUSSION · 
There has been much debate concerning the importance of humoral 
immunity in the host's recovery from primary HV infection (1, 29). 
Results of studies monitoring humoral antibody response to HV infections 
have shown that antibody production is relatively slow, and detectable 
leve~s of antibodies occur 1-2 weeks following initial infection (7, 8, 
29, 40). Antibody production was not detected ~ntil 3 weeks after 
infection in a study involving PRV (16). In the present study using 
BHV-5, antibody production could not be demonstrated until 17-21 days 
following initial inoculation of calves. Antibody production was of 
short duration, and 1:64 was the highest titer observed. Rouse and 
Babiuk (29) comment that because .antibodies appear · relatively late in 
HV infection, they may not be extremely important in recovery of the 
host from primary HV infection. Herpesviruses ·have been· shown to 
migrate both intercellularly (c~ll-to-cell) and _extracellularly with 
intercellular movement occuring first during infection. This movement 
enables the virus to pass from cell to cell with little exposure to 
humoral antibodies that might neutralize extracellular viruses. The 
intercellular movement of virus in the early phase of infection may be 
the cause of the delayed production of antibody. However, it is 
pussible that there is antibody production early in the ·infection, -but 
no antibody is detected due to it's rapid interaction with the antigen 
present. Allison has shown that animals with a general or selective 
deficiency in humoral antibody production often can recover from HV 
infections (29). Also, clinical disease can occur despite the 
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presence · of· circulating antibody in certain IN infections · (30 ,· 31). 
Although humoral antibody may not play an important role in 
recovery of the host from primary HV infection, it may be important in 
protecting against recrudescence of the virus or reinfection of the host 
by the virus (29). Results of other HV studies involving antibody 
production in animals in which the virus was reactivated have been 
inconsistent. Huck and co-workers (12) reported that BHV-1 neutralizing 
antibody was not detectable despite persistant infection of BHV-1 while 
Davies and Duncan (9) demonstrated antibody production following 
recrudescence of the virus. After DM treatment, antibody response to 
PRV antigen was detected by McAdaragh (16) in only 1 of 10 pigs 
previously inoculated with PRVo · Antibody production often, but not 
always, increased each time HSV underwent recrudescence following latent 
infection (23) • 
All 4 calves in the present study developed anamnestic antibody 
responses within a week after corticosteroid treatment. This possibly 
indicates the virus was reactivated and released by the host cells 
inducing antibody production. This study would support the importance 
of humoral immunity in protection against recrudescence or reinfection 
by the virus. 
Cell-mediated immunity is considered by many to be_ the most impor-
tant mechanism in recovery from primary HV infection (29). Individuals 
with defective CMI responses cannot successfully combat many viruses 
that pass inter~ellularly as do herpesviruses (1) • Lymphocyte stimu-
lation was detected within 2-5 days in subjects inoculated with 
herpesviruses such as PRV, HSV, and BHV-1 (2, 7, 8, 28, 30). In the 
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present study, a short-term CMI response to BHV-5 occurred in 3 of 4 
calves within 4 days after the primary inoculation, and an anamnestic 
CMI response occurred within a few days aft er each subsequent inocu-
lation with BHV-5. The SI decreased to pre-treatment levels 1-2 weeks 
after each inoculation indicating detectable levels of CMI are not 
present for long periods of time, but they are reactivated upon 
subsequent exposure of the virus. 
The role of CMI in protection against reinfection or recrudescence 
of herpesvirus after corticosteroid treatment is unresolved at this 
time. Shillitoe et ~· (34) detected an elevated CMI response when 
lesions from HSV infections re-occurred. Davies and Carmichael (8) de-
tected a CMI response 2-4 days after corticosteroid treatment of animal s 
previously inoculated with BHV-1.' In the present study, 2 of 3 calves 
that had a primary CMI response t o BHV-5 also had a CMI response 10 days 
after DM treatment. · The results would tend to implicate CMI as a pro-
t ective mechanism against reinfect i on or recrudescence of a herpesvirus. 
Studies involving PRV (16), HSV (37), and BHV-1 (8, 9, 33) demon-
s trated the ability of animal herpesviruses to become latent. When 
catt~e experimentally infected with BHV-1 were treated 3 months later 
with a corticosteroid, recrudescence of the virus occurred (17). 
Reactivation of BHV-5 from a latent s tate was demonstrated in 2 of 4 
calves in the present study. The vi rus was .isolated from a nasal swab 
and thoracic lymph node of 1 calf shortly after corticosteroid treatment 
and from the supernatant fluid of organ cultures of the trigeminal 
ganglion and spinal cord of another 2 1/2 months following cortico-
s t eroid treatment. Thus, it appears that BHV-5 is also capable of 
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becoming -latent within the host, and may ·be reactivated at a later date. 
It has been shown that latent HSV and BHV-1 may be harbored in the 
nervous system of the host, primarily in the trigeminal ganglion (17, 
19, 20, 33). The results of the present study demonstrate that BHV-5 
is s imilar to other herpesviruses in its ability to persist in a latent 
condition in the nerve tissue such as the trigeminal ganglion and spinal 
cord . 
Although the pathogenicity of BHV-5 in cattle is still uncertain, 
the ability of this virus to become latent and be reactivated could lead 
to many complications. Fo l lowing primary infection and latency, BHV-J 
may be reactivated a number of times throughout the life of an animal. 
Upon reactivation , not only is the health of the host jeopardized but 
also the host can be regarded as a potential source of infection to 
other susceptible animals (9 , 15). 
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CONCLUSIONS 
1. Bovid herpesvirus 5 induced a detectable level of humoral antibody 
in calves approximately 17-21 days after initial inoculation with 
no noticeable anamnestic response upon subsequent infection. An 
increase in antibody production was ·detected within a week following 
corticosteroid treatment of previously infected calves. 
2. Bovid herpesvirus 5 caused short-term CMI responses in calves within 
4 days after initial inoculation and anamnestic responses upon 
subsequent reinfection. A CMI response was demonstrated within 10 
days following steroid-induced recrudescence of the virus · 
3. Bovid herpesvirus 5 has the ability to become latent in the host and 
be reactivated by corticosteroid treatment. 
4. Latent BHV-5 was located in the nerve tissue as shown by isolation 
of the virus from organ cultures of the trigeminal ganglion and 
spinal cord. 
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